Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Commun Biol ; 5(1): 895, 2022 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-36050388

RESUMO

Glioblastoma (GBM) is the most aggressive primary brain tumour for which both effective treatments and efficient tools for an early-stage diagnosis are lacking. Herein, we present curcumin-based fluorescent probes that are able to bind to aldehyde dehydrogenase 1A3 (ALDH1A3), an enzyme overexpressed in glioma stem cells (GSCs) and associated with stemness and invasiveness of GBM. Two compounds are selective versus ALDH1A3, without showing any appreciable interaction with other ALDH1A isoenzymes. Indeed, their fluorescent signal is detectable only in our positive controls in vitro and absent in cells that lack ALDH1A3. Remarkably, in vivo, our Probe selectively accumulate in glioblastoma cells, allowing the identification of the growing tumour mass. The significant specificity of our compounds is the necessary premise for their further development into glioblastoma cells detecting probes to be possibly used during neurosurgical operations.


Assuntos
Aldeído Oxirredutases , Neoplasias Encefálicas , Curcumina , Glioblastoma , Aldeído Desidrogenase/química , Aldeído Desidrogenase/metabolismo , Aldeído Oxirredutases/química , Aldeído Oxirredutases/metabolismo , Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/cirurgia , Curcumina/metabolismo , Curcumina/farmacologia , Diagnóstico Precoce , Corantes Fluorescentes/metabolismo , Glioblastoma/diagnóstico , Glioblastoma/metabolismo , Glioblastoma/cirurgia , Humanos , Células-Tronco Neoplásicas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA